| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2281650
Max Phase: Preclinical
Molecular Formula: C27H28N8O2
Molecular Weight: 496.58
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCc1nc2ccn(C(=O)N(CC)CC)c(=O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1
Standard InChI: InChI=1S/C27H28N8O2/c1-4-23-28-22-15-16-34(27(37)33(5-2)6-3)26(36)24(22)35(23)17-18-11-13-19(14-12-18)20-9-7-8-10-21(20)25-29-31-32-30-25/h7-16H,4-6,17H2,1-3H3,(H,29,30,31,32)
Standard InChI Key: PBBPKZKNOYZUMC-UHFFFAOYSA-N
Associated Targets(non-human)
Angiotensin II receptor (AT-1) type-1 1480 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 496.58 | Molecular Weight (Monoisotopic): 496.2335 | AlogP: 3.97 | #Rotatable Bonds: 7 |
| Polar Surface Area: 114.59 | Molecular Species: ACID | HBA: 8 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 4.23 | CX Basic pKa: 1.78 | CX LogP: 3.87 | CX LogD: 2.27 |
| Aromatic Rings: 5 | Heavy Atoms: 37 | QED Weighted: 0.36 | Np Likeness Score: -1.46 |
References
| 1. Sharma MC, Kohli DV. (2013) A comprehensive structureactivity analysis 2,3,5-trisubstituted 4,5-dihydro-4-oxo-3H-imidazo [4,5-c] pyridine derivatives as angiotensin II receptor antagonists: using 2D- and 3D-QSAR approach, 22 (2): [10.1007/s00044-012-0040-z] |
Source
Source(1):